Farrerol
Farrerol has antioxidative activity.Farrerol modulates TAP and BNBD5 gene expression in mammary gland, enhances bMEC defense against S. aureus infection and could be useful in protection against bovine mastitis. Farrerol inactivates KEAP-1 or activates the Akt, p38 and ERK to facilitate the release of Nrf2 from Keap1 and subsequent reduces the intracellular production of reactive oxygen species via the induction of HO-1 expression. Farrerol has protective effects against H2O2-induced apoptosis in EA.hy926 cells, and suggests that Farrerol is a potential candidate for the intervention of endothelial-injury-associated cardiovascular diseases.
Product Specifications
CAS Number
24211-30-1
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 125 mg/mL (416.24 mM)
Smiles
CC1=C (C2=C (C (=C1O) C) OC (CC2=O) C3=CC=C (C=C3) O) O
Molecular Formula
C17H16O5
Molecular Weight
300.31
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
UGT1A10 (UDP-glucuronosyltransferase 1A10, UDP-glucuronosyltransferase 1-10, UDPGT 1-10, UGT1*10, UGT1-10, UGT1.10, UGT1, UDP-glucuronosyltransferase 1-J, UGT1J, UGT-1J, GNT1) (FITC)
UGT1A10 (UDP-glucuronosyltransferase 1A10, UDP-glucuronosyltransferase 1-10, UDPGT 1-10, UGT1*10, UGT1-10, UGT1.10, UGT1, UDP-glucuronosyltransferase 1-J, UGT1J, UGT-1J, GNT1) (FITC)
Lentiviral mouse Mrpl24 shRNA (UAS) - Lentiviral mouse Mrpl24 shRNA (UAS) (100)
Trans-1,2-Cyclohexanediaminetetraacetic acid